Market Tracker

12/19 11:01pm ET

Alkermes Plc (NASDAQ:ALKS)

58.88
Data as of Dec 19
 +1.20 / +2.08%
Today’s Change
38.49
Today|||52-Week Range
59.69
+44.81%
Year-to-Date

Today’s Trading

Previous close57.68
Today’s open57.78
Day’s range56.82 - 59.00
Volume1,722,870
Average volume (3 months)875,420
Market cap$8.6B
Dividend yield--
Data as of 4:00pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-79.92%
Earnings growth (next 5 years)+8.28%
Revenue growth (last year)+47.59%
P/E ratio490.7
Price/Sales5.42
Price/Book8.27

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.09-0.18%
MDVNMedivation Inc-0.83-0.76%
SLXPSalix Pharmaceutical...-1.25-1.06%
PCYCPharmacyclics Inc-1.89-1.42%
Data as of 4:03pm ET, 12/19/2014

Financials

Next reporting dateDecember 22, 2014
EPS forecast (this quarter)$0.02
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts